These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28890189)

  • 1. Human papillomavirus vaccination coverage using two-dose or three-dose schedule criteria.
    Lin X; Rodgers L; Zhu L; Stokley S; Meites E; Markowitz LE
    Vaccine; 2017 Oct; 35(43):5759-5761. PubMed ID: 28890189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
    Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices.
    Meites E; Kempe A; Markowitz LE
    MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(49):1405-1408. PubMed ID: 27977643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.
    Walker TY; Elam-Evans LD; Singleton JA; Yankey D; Markowitz LE; Fredua B; Williams CL; Meyer SA; Stokley S
    MMWR Morb Mortal Wkly Rep; 2017 Aug; 66(33):874-882. PubMed ID: 28837546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.
    Pingali C; Yankey D; Elam-Evans LD; Markowitz LE; Williams CL; Fredua B; McNamara LA; Stokley S; Singleton JA
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1183-1190. PubMed ID: 34473682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Chesson HW; Curtis CR; Gee J; Bocchini JA; Unger ER;
    MMWR Recomm Rep; 2014 Aug; 63(RR-05):1-30. PubMed ID: 25167164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing human papillomavirus vaccination at the recommended age.
    Lin X; Shrader L; Rodgers L; Stokley S; Markowitz LE
    Vaccine; 2019 Jan; 37(5):686-689. PubMed ID: 30591254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018.
    Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Fredua B; Singleton JA; Stokley S
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):718-723. PubMed ID: 31437143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation.
    Saslow D; Andrews KS; Manassaram-Baptiste D; Smith RA; Fontham ETH;
    CA Cancer J Clin; 2020 Jul; 70(4):274-280. PubMed ID: 32639044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
    Petrosky E; Bocchini JA; Hariri S; Chesson H; Curtis CR; Saraiya M; Unger ER; Markowitz LE;
    MMWR Morb Mortal Wkly Rep; 2015 Mar; 64(11):300-4. PubMed ID: 25811679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):626-9. PubMed ID: 20508593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule.
    Cloessner EA; Stokley S; Yankey D; Markowitz LE
    Hum Vaccin Immunother; 2016 Jun; 12(6):1375-80. PubMed ID: 26587886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.
    Stokley S; Jeyarajah J; Yankey D; Cano M; Gee J; Roark J; Curtis RC; Markowitz L; ;
    MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(29):620-4. PubMed ID: 25055185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012.
    Cullen KA; Stokley S; Markowitz LE
    Acad Pediatr; 2014; 14(5):497-504. PubMed ID: 24954170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian school-based HPV vaccine programs and policy considerations.
    Shapiro GK; Guichon J; Kelaher M
    Vaccine; 2017 Oct; 35(42):5700-5707. PubMed ID: 28893472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.
    Meites E; Szilagyi PG; Chesson HW; Unger ER; Romero JR; Markowitz LE
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(32):698-702. PubMed ID: 31415491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(50):1705-8. PubMed ID: 22189893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inconclusive evidence for non-inferior immunogenicity of two- compared with three-dose HPV immunization schedules in preadolescent girls: A systematic review and meta-analysis.
    Donken R; Knol MJ; Bogaards JA; van der Klis FR; Meijer CJ; de Melker HE
    J Infect; 2015 Jul; 71(1):61-73. PubMed ID: 25709084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.